---
title: Annex III — Technical Documentation on Post-Market Surveillance (PMS)
description: EU MDR 2017/745 Annex III sets out the content requirements for technical documentation on post-market surveillance, including PMS plan, PMS report and Periodic Safety Update Report (PSUR).
regulation: EU MDR 2017/745
annex: Annex III
---

# Annex III — Technical Documentation on Post-Market Surveillance (PMS)

**Source**: [EU MDR 2017/745 Annex III](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745) | OJ L 117, 5.5.2017

## PMS Documentation System

### PMS Plan (Article 84)

Manufacturers shall establish, document and implement a PMS plan covering:

- Proactive and reactive methods for collecting post-market data
- Methods for evaluating collected data
- Appropriate indicators and threshold values
- Relevant databases and data sources

**Data Sources**:
- Reports of serious incidents and field safety corrective actions
- Records of non-serious incidents and complaints from economic operators, users and patients
- Literature reviews (scientific literature, clinical databases)
- Data from similar devices
- EUDAMED database information

### PMS Report (Article 85) — Class I Devices

- Updated at least every 2 years
- Shall be incorporated into the technical documentation

### Periodic Safety Update Report (PSUR) (Article 86) — Class IIa/IIb/III Devices

| Device Class | PSUR Update Frequency |
|-------------|----------------------|
| Class IIa | At least every 2 years |
| Class IIb | At least annually |
| Class III | At least annually |

**PSUR Content**:
- Conclusions regarding the device and its intended purpose
- Main findings and conclusions
- Assessment of the benefit-risk ratio
- Sales volume estimates
- Estimated frequency of device use (where feasible)

## Relationship with Clinical Evaluation

PMS data shall feed back into:
- Updates to the Clinical Evaluation Report (CER)
- Adjustments to the Post-Market Clinical Follow-up (PMCF) plan
- Updates to risk management documentation

## Related Pages

- [Annex II — Technical Documentation](./annex-ii-technical-documentation)
- [Annex XIV — Clinical Evaluation](./annex-xiv-clinical-evaluation)

## Official Sources

- [EUR-Lex: EU MDR 2017/745 full text (including Annex III)](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)
- [MDCG 2022-21: Guidance on PSUR](https://health.ec.europa.eu/system/files/2022-12/mdcg_2022-21_en.pdf)
